Medical Health & Life Science Research News

Cancer/Tumor Profiling Market to advance at a 19% CAGR in near future

Cancer Profiling Market

The growth in the European market for cancer/tumor profiling is mainly led by growing aging population, increasing prevalence of chronic pain, and neurological disorders and R&D infrastructure. Cancer/tumor profiling market size is projected to reach $87.1 billion by 2023 by P&S Intelligence.

The changing environment and adoption of unhealthy lifestyle habits, such as tobacco consumption and smoking, exposure to harmful radiations along with other factors have led to a massive increase in the incidence of cancer.  As per the World Health Organization, global cancer burden has risen to 9.6 million cancer deaths and 18.1 million new cases in 2018. 

Further, the American Cancer Society reported that in 2017, approximately 1,688,780 new cancer cases were expected to be diagnosed in the U.S. and as many as 600,920 Americans were expected to lose their lives to cancer in the same year, which translates to 1,650 patients succumbing to cancer per day.

Request for report sample at: www.psmarketresearch.com/market-…ort-sample

The International Agency of Research on Cancer has predicted that by 2030, the global cancer burden would grow to 21.7 million new cases, mainly due to the increasing aging population. Cancer is an umbrella term that represents a large group of diseases and there are more than 100 types of cancer.

In this disease, multiple types of tissues are affected, which contain different biomarkers. Therefore, to correctly identify these biomarkers for diagnostic purposes, cancer/ tumor profiling is the need of the hour as certain cancer types affect specific sets of genes, which can be extremely helpful in drawing a correct diagnosis.

Cancer is a genetic disease, which is a result of changes that occur in the genes of cells that continue to divide uncontrollably.  As cancer affects numerous genes, the need for cancer profiling is being felt, which is done using various technologies, namely microarray, next generation sequencing (NGS), in-situ hybridization (ISH), immunohistochemistry (IHC), and quantitative polymerase chain reaction (qPCR). 

During 2013–2016, the most popular technology for generating tumor/cancer profiles was the NGS. This can be credited to the immense popularity of this technology among researchers and scientists as it helps in parallelly sequencing millions of fragments per run.

It is a high-throughput process which translates into sequencing of thousands of genes at a time. Further, this technology also has the scope of discovering rare or novel variants.

Owing to the aforementioned factors, this technology would continue to remain a favorite among end users. This is expected to lead the cancer/tumor p…ing market to witness significant growth at a 19.0% CAGR in the coming years, as estimated in a P&S Intelligence study.

Cancer/tumor profiling can be used for various purposes, such as prognostics, personalized medicine, biomarker discovery, diagnostics, and others. During 2013–2016, cancer/tumor profiling was most extensively used in the personalized medicine domain.

This is attributed to the high success rates achieved in cancer treatment using personalized therapy, as it offers a tailormade treatment specific to an individual. This is expected to continue being the most popular application area of cancer profiling in the coming years as well.

Pre-Access Inquiry at: www.psmarketresearch.com/send-en…ing-market

GLOBAL CANCER/TUMOR PROFILING MARKET SEGMENTATION

By Technology

  • Next generation sequencing (NGS)
    • By region
  • Quantitative polymerase chain reaction (QPCR)
    • By region
  • Immunohistochemistry (IHC)
    • By region
  • In-situ hybridization (ISH)
    • By type
      • Fluorescent in situ hybridization (FISH)
      • Chromogenic in situ hybridization (CISH)
    • By region
  • Microarray
    • By region

By Technique

  • Genomics
    • By region
  • Proteomics
    • By region
  • Epigenetics
    • By region
  • Metabolomics
    • By region

By Application

  • Personalized medicine
    • By region
  • Diagnostics
    • By region
  • Biomarker discovery
    • By region
  • Prognostics
    • By region

News From

P&S IntelligenceP&S Intelligence
Category: Market Research Publishers and RetailersCompany about: Prescient & Strategic (P&S) Intelligence Private Limited (formerly known as P&S Market Research Private Limited) was born out of the idea of helping businesses achieve breakthroughs through intelligent decision making, underpinned by a thorough understanding of industry dynamics. As a market intelligence and consulting firm, we strive to provide our clients with first-string market insights to facilitate intelligent decision making.At P&S Intelligence, we offer a multi-dimensional analytical lan ...
This email address is being protected from spambots. You need JavaScript enabled to view it.